Archon Capital Management’s Core Laboratories CLB Stock Holding History

Archon Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Buy	+178,700	New	+$2.55M	0.85%	33
2026 Q1	–	Sell	-117,252	Closed	-$1.88M	–	48
2025 Q4	$1.88M	Buy	+117,252	New	+$1.75M	1.07%	31
2017 Q4	–	Sell	-22,820	Closed	-$2.25M	–	19
2017 Q3	$2.25M	Hold	22,820	–	–	1.21%	19
2017 Q2	$2.31M	Hold	22,820	–	–	1.88%	19
2017 Q1	$2.64M	Sell	22,820 -4,250	-16%	-$494K	3.75%	10
2016 Q4	$3.25M	Buy	27,070 +2,470	+10%	+$273K	5.59%	9
2016 Q3	$2.76M	Sell	24,600 -10,300	-30%	-$1.19M	7.04%	8
2016 Q2	$4.32M	Sell	34,900 -37,600	-52%	-$4.54M	5.2%	7
2016 Q1	$8.15M	Sell	72,500 -4,200	-5%	-$436K	8.08%	4
2015 Q4	$8.34M	Sell	76,700 -24,500	-24%	-$2.8M	5.93%	5
2015 Q3	$10.1M	Buy	101,200 +34,100	+51%	+$3.71M	8.88%	2
2015 Q2	$7.65M	Sell	67,100 -40,900	-38%	-$4.96M	7.49%	6
2015 Q1	$11.3M	Buy	108,000 +52,000	+93%	+$5.54M	9.88%	3
2014 Q4	$6.74M	Buy	+56,000	New	+$7.36M	4.74%	9

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Archon Capital Management's CLB Position: Q2 2026 in Review

Archon Capital Management opened a new position in Core Laboratories (CLB) in Q2 2026: 178,700 shares worth $2.08M. The stake represents 0.85% of the portfolio and ranks #33 among its holdings. This is a return to the name: Archon Capital Management previously reported a position in CLB as recently as Q4 2025.

Archon Capital Management first reported a position in CLB in Q4 2014 and has held it in 14 quarters since. The position peaked at $11.3M in Q1 2015. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Archon Capital Management held 178,700 shares of Core Laboratories worth $2.08M as of Q2 2026.
Core Laboratories was a new Archon Capital Management position in Q2 2026.
Core Laboratories made up 0.85% of Archon Capital Management's portfolio in Q2 2026, its #33 holding.
Archon Capital Management first reported a position in Core Laboratories in Q4 2014 and has held it in 14 quarters since.
Archon Capital Management's Core Laboratories position peaked at $11.3M in Q1 2015.
187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Archon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.